INNV InnovAge Holding Earnings and EPS analysis

Relative Growth: Rel. Growth: 59

Relative Strength: Rel. Strength: 84

Relative Valuation: Rel. Valuation: 27

Relative Profitability: Rel. Profitability: 40

EPS in 2026 (TTM): -$0.02

Last Report Period Date: Jun 30, 2026

Based on the company's latest reports for June 2026, the current 12-month EPS is -$0.02. InnovAge Holding's earnings per share in 2026 was reported at -$0.02, marking a rise from -$0.22 in 2025. In the quarterly report ending on Jun 30, 2026, INNV's earnings per share amounted to $0.06.

INNV earnings history

Historical annual and quarterly earnings per share (EPS) data for InnovAge Holding

EPS (TTM)

-$0.02

EPS Growth YoY (Quarterly)

N/A

EPS (Quarterly)

$0.06

EPS Growth (Quarterly)

127.3%

InnovAge Holding had an yealy earnings per share of -$0.02, showing a rise of 90.9% from -$0.22 recorded in 2025. The trailing twelve months EPS for INNV is -$0.02 as of June 2026. InnovAge Holding's full-year EPS for 2025 was -$0.22, a 37.5% decline compared to the previous year.

INNV EPS vs price chart

INNV EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

N/A

EPS growth YoY

90.9%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

INNV Earnings Waterfall

Breakdown of revenue, profit and net income for InnovAge Holding

INNV Earnings vs Peers

What are the earnings of INNV compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
ANIP Ani Pharmaceuticals Inc	15.41	436.5%	N/A	N/A
UTHR UNITED THERAPEUTICS Corp	16.18	14%	23.5%	20.9%
MRK Merck & Co Inc	116.6	8%	8.4%	21.2%
COCP Cocrystal Pharma Inc	N/A	54.7%	N/A	N/A
INNV InnovAge Holding Corp	N/A	90.9%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.